Rznomics Inc. Liver Cancer Drug Candidate Secures Fast Track Designation ...Middle East

Anticancer drug utilizing Trans-splicing Ribozyme technology Second Fast Track Designation following brain cancer approval SEONGNAM, South Korea, Feb. 18, 2025 /PRNewswire/ -- Rznomics announced on the 14th that its anticancer drug, RZ-001, has received Fast Track Designation from the U.S....

Read More Details
Finally We wish PressBee provided you with enough information of ( Rznomics Inc. Liver Cancer Drug Candidate Secures Fast Track Designation )

Also on site :

• Reform MP James McMurdock suspends himself from party over ‘business propriety during pandemic’
• Police ramp up patrols at Ontario Beach Park after fights, visitors hope for a peaceful holiday weekend
• Fires break out across Denver metro, several reportedly caused by fireworks